| Patents for A61P 9 - Drugs for disorders of the cardiovascular system (159,484) |
|---|
| 04/14/2011 | US20110086843 Thiazole Derivatives and Use Thereof |
| 04/14/2011 | US20110086838 Novel compounds as cannabinoid receptor ligands |
| 04/14/2011 | US20110086832 Novel compounds as cannabinoid receptor ligands |
| 04/14/2011 | US20110086815 Novel compositions containing xanthohumol-cyclodextrin complexes |
| 04/14/2011 | US20110086808 Modified therapeutic agents |
| 04/14/2011 | US20110086801 Prevention and reduction of blood loss |
| 04/14/2011 | US20110086795 Small peptide modulators of potassium channel trafficking |
| 04/14/2011 | US20110086119 Preparation for the relief of disease |
| 04/14/2011 | US20110086105 Methods for identifying novel nucleic acid regulatory elements and compounds that affect the regulation |
| 04/14/2011 | US20110086097 Manufacture process for the preparation of an iron containing phosphate adsorbent |
| 04/14/2011 | US20110086096 Modified release 1- [ (3-hydroxy-adamant-1-ylamino)-acetyl] -pyrrolidine-2 (s) -carbonitrile formulation |
| 04/14/2011 | US20110086094 Capsule for the prevention of cardiovascular diseases |
| 04/14/2011 | US20110086092 Pharmacuetical tablets containing a plurality of active ingredients |
| 04/14/2011 | US20110086089 Use of p27kip1 for the prevention and treatment of heart failure |
| 04/14/2011 | US20110086069 Pharmaceutical formulations of nitrite and uses thereof |
| 04/14/2011 | US20110086050 Glycoprotein compositions |
| 04/14/2011 | US20110086031 Inhibition Of The Activity Of The Capsaicin Receptor In The Treatment Of Obesity Or Obesity-Related Diseases And Disorders |
| 04/14/2011 | US20110086009 Cell line for the production of prostacyclin and uses thereof |
| 04/14/2011 | US20110086001 Compliant biocompatible polymer compositions for medical uses |
| 04/14/2011 | US20110085976 Methods for detecting cardiac damage |
| 04/14/2011 | US20110085975 Hypoxia-selective, weakly basic 2-nitroimidazole delivery agents and methods of use thereof |
| 04/14/2011 | US20110083984 Substituted 2,3-dihydroimidazo[1,2-c]quinazoline Derivatives Useful for Treating Hyper-Proliferative Disorders and Diseases Associated with Angiogenesis |
| 04/14/2011 | DE102009049662A1 2,5-Disubstituierte 2H-Indazole als EP2-Rezeptor-Antagonisten 2,5-disubstituted 2H-indazoles as EP2-receptor antagonists |
| 04/14/2011 | CA2777209A1 Tricyclic and tetracyclic systems with activity on the central-nervous and vascular systems |
| 04/14/2011 | CA2776882A1 Preparation and use of stromal cells for treatment of cardiac diseases |
| 04/14/2011 | CA2776581A1 Methods for the prevention or treatment of heart failure |
| 04/14/2011 | CA2775747A1 Methods and compositions related to clot-binding lipid compounds |
| 04/14/2011 | CA2774557A1 Lactobacillus plantarum strains as hypocholesterolemic agents |
| 04/14/2011 | CA2774215A1 Bicyclic heterocycles and their use as ccr2 receptor antagonists |
| 04/13/2011 | EP2309261A1 Methods for evaluating tissue morphogenesis and morphogenic activity |
| 04/13/2011 | EP2308963A2 System for processing lipoaspirate cells |
| 04/13/2011 | EP2308880A1 Tetracyclic compound |
| 04/13/2011 | EP2308861A1 Macrocyclic compounds useful as pharmaceuticals |
| 04/13/2011 | EP2308855A1 2,4-Diaminopyrimidine derivatives |
| 04/13/2011 | EP2308846A2 Caspase inhibitors and uses thereof |
| 04/13/2011 | EP2308845A2 Caspase inhibitors and uses thereof |
| 04/13/2011 | EP2308844A2 Caspase inhibitors and uses thereof |
| 04/13/2011 | EP2308838A1 Nitrogen-containing aromatic heterocyclyl compound |
| 04/13/2011 | EP2308833A2 Cyclic protein tyrosine kinase inhibitors |
| 04/13/2011 | EP2308562A2 Azetidine ring compounds and drugs comprising the same |
| 04/13/2011 | EP2308510A1 Agent for regeneration and/or protection of nerves |
| 04/13/2011 | EP2308502A1 Method to induce neovascular formation and tissue regeneration |
| 04/13/2011 | EP2308495A1 Method and composition for treating peripheral vascular diseases |
| 04/13/2011 | EP2308493A1 Ameliorating or therapeutic agent for dyslipidemia |
| 04/13/2011 | EP2308488A1 Use of celivarone for the preparation of a medicament for use in the prevention of implantable cardioverter defibrillator interventions or death |
| 04/13/2011 | EP2308481A1 Combination therapy for the treatment of hypertension |
| 04/13/2011 | EP2307447A2 Natriuretic polypeptides with unique pharmacologic profiles |
| 04/13/2011 | EP2307396A1 Renin inhibitors and method of use thereof |
| 04/13/2011 | EP2307387A1 Novel heterocyclyl compounds for treatment of cardiovascular disease |
| 04/13/2011 | EP2307380A1 N'-nitroxyalkylnicotinamides for the treatment of cardiovascular diseases |
| 04/13/2011 | EP2307379A2 Organic compounds |
| 04/13/2011 | EP2307371A2 Organic compounds |
| 04/13/2011 | EP2307026A1 The use of androgens for vascular regeneration and endothelial repair |
| 04/13/2011 | EP2307012A1 Nitrogen heterocycle derivatives as proteasome modulators |
| 04/13/2011 | EP2125744B1 Cycloalkylamine substituted isoquinolone and isoquinolinone derivatives |
| 04/13/2011 | EP2101778B1 Ectoin for treating vascular leaks |
| 04/13/2011 | EP2051714B1 Drug combinations for the treatment of respiratory tract diseases |
| 04/13/2011 | EP2018165B1 Fgf-peceptor agonist dimeric compounds |
| 04/13/2011 | EP1674566B1 Method of promoting subsistence and/or proliferation of neural stem cell and promoting extension of neurite, promoter therefor, pharmaceutical composition containing neural stem cell, method of assay and method of screening |
| 04/13/2011 | EP1542978B1 Novel bio-active molecules |
| 04/13/2011 | EP1539763B1 Azaindole kinase inhibitors |
| 04/13/2011 | CN1993116B Use of discharge protein inhibitors in preparing medicine for improving bioavailability of a renin inhibitor |
| 04/13/2011 | CN1943718B A Chinese traditional medicinal composition and its preparation method |
| 04/13/2011 | CN1939296B Theapolyphenol composition and its preparation |
| 04/13/2011 | CN1931205B Kindir leaf total flavone extract and its preparation and application |
| 04/13/2011 | CN1822851B Stable analogs of peptide and polypeptide therapeutics |
| 04/13/2011 | CN1813711B Use of isoflavone compound |
| 04/13/2011 | CN1723019B Compounds having anti-proliferative properties |
| 04/13/2011 | CN102015722A Tricyclic pyridine derivatives, medicaments containing such compounds, their use and process for their preparation |
| 04/13/2011 | CN102015712A Heterocyclic compounds as adenosine receptor antagonist |
| 04/13/2011 | CN102015685A Substituted dihydropyrazolones as inhibitors of HIF-prolyl-4-hydroxylases |
| 04/13/2011 | CN102015682A 3, 4 - substituted piperidine derivatives as renin inhibitors |
| 04/13/2011 | CN102015678A Fused pyridines active as inhibitors of c-Met |
| 04/13/2011 | CN102015675A Chlorothiophene-amides as inhibitors of coagulation factors Xa and thrombin |
| 04/13/2011 | CN102015658A Benzimidazole derivatives |
| 04/13/2011 | CN102015656A Phenylpropionic acid derivative and use thereof |
| 04/13/2011 | CN102015644A Hydroxyalkanyl amides as modulators of chemokine receptor activity |
| 04/13/2011 | CN102015638A Long-chain fatty acid elongation enzyme inhibitor comprising arylsulfonyl derivative as active ingredient |
| 04/13/2011 | CN102015637A Novel phenylpyrrole derivative |
| 04/13/2011 | CN102015636A Azetidines and cyclobutanes as histamine H3 receptor antagonists |
| 04/13/2011 | CN102015626A 4-trimethylammonio-butyrates as CPT2 inhibitors |
| 04/13/2011 | CN102015026A Novel nip thiazole derivatives as inhibitors of 11-beta-hydroxysteroid dehydrogenase-1 |
| 04/13/2011 | CN102014949A Vascular aging inhibitor and anti-aging formulation |
| 04/13/2011 | CN102014943A Nutritional compositions for promotion of bone growth and maintenance of bone health comprising extracts of for example rosemary or caraway |
| 04/13/2011 | CN102014933A Use of deuterium oxide as an elastase inhibitor |
| 04/13/2011 | CN102014917A Use of 2,4-pyrimidinediamines for the treatment of atherosclerosis |
| 04/13/2011 | CN102010460A Tea seed polypeptide and preparation method thereof |
| 04/13/2011 | CN102010456A Method for extracting pseudoginsenoside RT5 and medical application |
| 04/13/2011 | CN102010373A Benzimidazole derivatives, compositions containing them, preparation thereof and uses thereof |
| 04/13/2011 | CN102010324A Aspirin-triggered lipid mediators |
| 04/13/2011 | CN102010298A Indene derivatives as pharmaceutical agents |
| 04/13/2011 | CN102008727A Injection-purpose medicine composition for improving stability of ligustrazine medicine injection formulation and preparation method of injection-purpose medicine composition |
| 04/13/2011 | CN102008718A Application of SIRT (Silent Mating Type Information Regulation 2 Homolog 1) to prepare medicine used for regulating down the expression of cyclin D1 |
| 04/13/2011 | CN102008712A Trandolapril-containing compound preparation for curing hypertension |
| 04/13/2011 | CN102008711A Compound preparation containing enalapril for treating hypertension |
| 04/13/2011 | CN102008710A Lisinopril-containing compound preparation for treating hypertension |
| 04/13/2011 | CN102008709A Moexipril-contained compound preparation for treating hypertension |
| 04/13/2011 | CN102008708A Ramipril-contained compound preparation for treating hypertension |
| 04/13/2011 | CN102008707A Quinapril-contained compound preparation for treating hypertension |
| 04/13/2011 | CN102008694A Haemorrhoid paste containing Zingiber Corallinum Hance essential oil |